𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Limitations of enzyme replacement therapy: Current and future

✍ Scribed by J. E. Wraith


Publisher
Springer
Year
2006
Tongue
English
Weight
228 KB
Volume
29
Category
Article
ISSN
0141-8955

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Current developments and future prospect
✍ Asmeret G. Kidane; Gaetano Burriesci; Patricia Cornejo; Audrey Dooley; Sandip Sa πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 279 KB

## Abstract Valve replacement is the most common surgical treatment in patients with advanced valvular heart disease. Mechanical and bio‐prostheses have been the traditional heart valve replacements in these patients. However, currently the heart valves for replacement therapy are imperfect and sub

Fabry disease: enzyme replacement therap
✍ MR Bongiorno; G Pistone; M AricΓ² πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 164 KB

## ABSTRACT Fabry disease is a multisystem disorder associated with wide variability in clinical expression. Fabry disease is an X‐linked lysosomal storage disorder caused by a deficiency of α‐galactosidaseΒ A. The enzyme defect leads to the systemic accumulation of glycosphingolipids with α‐galacto

Limitations of current Parkinson's disea
✍ Olivier Rascol; Pierre Payoux; Fabienne Ory; Joaquim J. Ferreira; Christine Bref πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 117 KB πŸ‘ 2 views
Immunophotodynamic therapy: Current deve
✍ Gerald G. Miller; J. William Lown πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 453 KB πŸ‘ 2 views

Photodynamic therapy (PDT) may offer an enhanced therapeutic index via one or more of the following modalities: a) preferential photosensitizer uptake by the target tissue, b) specific illumination of target tissue to excite the photosensitizer, c) strategic timing of light application to minimize t